On February 20, 2024 the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application for TECVAYLI® (teclistamab) for a reduced dosing frequency of 1.5 mg/kg every two weeks in patients with relapsed or refractory multiple myeloma who have achieved and maintained a complete response or better for a minimum of six months.There is a continued unmet need for patients with multiple myeloma and this approval allows increased flexibility in dosing schedule for appropriate patients with a weight-based regimen.
Why you wanted to isolate T-cells? To GMO production or organs? What is truth reason? Karyopharm and Amgen? Ot looks like very far from treatment. Why you can't treat HIV? Acyklovir does not work?
On February 20, 2024 the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application for TECVAYLI® (teclistamab) for a reduced dosing frequency of 1.5 mg/kg every two weeks in patients with relapsed or refractory multiple myeloma who have achieved and maintained a complete response or better for a minimum of six months.There is a continued unmet need for patients with multiple myeloma and this approval allows increased flexibility in dosing schedule for appropriate patients with a weight-based regimen.
I'll try this treatment next month, so this video answered a lot of my questions. It was very helpful, thank you.
Great presentation. Thanks
Worst advice to give was to keep up on Covid vaccines
Why you wanted to isolate T-cells? To GMO production or organs? What is truth reason? Karyopharm and Amgen? Ot looks like very far from treatment. Why you can't treat HIV? Acyklovir does not work?